Effect of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in rural Gambia 10 years after its introduction: A population-based cross-sectional study
Ten years after the introduction of PCV13 in the Gambia, residual VT carriage persists, particularly in age groups in whom direct protection from immunization in infancy has waned. A booster dose or catch-up vaccinations could aid control of VT circulation.
Authors
- Golam Sarwar (ORCID: https://orcid.org/0000-0002-3573-8457)
- Brian Greenwood (ORCID: https://orcid.org/0000-0001-5725-9118)
- Stefan Flasche (ORCID: https://orcid.org/0000-0002-5808-2606)
- Grant Mackenzie (ORCID: https://orcid.org/0000-0002-4994-2627)
- Kevin van Zandvoort (ORCID: https://orcid.org/0000-0002-7770-0537)
- Rasheed Salaudeen
- Ousman Barjo (ORCID: https://orcid.org/0000-0002-9565-1839)
- Minteh Molfa
- Isaac Osei (ORCID: https://orcid.org/0000-0002-9370-9363)
- Jane Bruce
- Emmanuel Mendy
- I Mohammed Nuredin
Institutions
- University of London (GB)
- London School of Hygiene & Tropical Medicine (GB)
- MRC Unit the Gambia (GM)
Publication Details
- Journal
- Vaccine
- Published
- 2025-04-28
- DOI
- https://doi.org/10.1016/j.vaccine.2025.127181
- Citations
- 4
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- Bill and Melinda Gates Foundation